Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast

Microbiology

Volumn 154, Issue 10, 2008, Pages 3154-3164

  Paluszynski, John P ^a   Klassen, Roland ^a   Meinhardt, Friedhelm ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; FLUCYTOSINE; ANTIFUNGAL AGENT; CARRIER PROTEIN; CYTOCHROME P450; CYTOSINE DEAMINASE; ERG11 PROTEIN, S CEREVISIAE; FCY2 PROTEIN, S CEREVISIAE; FUNGAL DNA; GLYCOSYLTRANSFERASE; OROTATE PHOSPHORIBOSYLTRANSFERASE; OXIDOREDUCTASE; SACCHAROMYCES CEREVISIAE PROTEIN; STEROL DELTA 5 DESATURASE; STEROL DELTA-5 DESATURASE; URACIL PHOSPHORIBOSYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; FUNGAL STRAIN; MUTANT; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; AMINO ACID SEQUENCE; ANTIFUNGAL RESISTANCE; DRUG EFFECT; ENZYMOLOGY; FUNGAL GENE; GENETIC TRANSFORMATION; GENETICS; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MUTATION;

SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOSINE DEAMINASE; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; FLUCYTOSINE; GENES, FUNGAL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; OROTATE PHOSPHORIBOSYLTRANSFERASE; OXIDOREDUCTASES; PENTOSYLTRANSFERASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSFORMATION, GENETIC;

EID: 55549142203     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2008/020107-0     Document Type: Article

References (52)

1. Agarwal, A. K., Rogers, P. D., Baerson, S. R., Jacob, M. R., Barker, K. S., Cleary, J. D., Walker, L. A., Nagle, D. G. & Clark, A. M. (2003). Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 278, 34998-35015.
2. Alexander, B. D. & Perfect, J. R. (1997). Antifungal resistant trends towards the year 2000: Implications of therapy and new approaches. Drugs 54, 657-678.
3. Allendoerfer, R., Marquis, A. J., Rinaldi, M. J. & Graybill, J. R. (1991). Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrob Agents Chemother 35, 726-729.
4. Arthington, B. A., Bennett, L. G., Skatrud, P. L., Guynn, C. J., Barbuch, R. J., Ulbright, C. E. & Bard, M. (1991). Cloning, disruption, and sequence of the gene encoding yeast C-5 sterol desaturase. Gene 102, 39-44.
5. Bammert, G. F. & Fostel, J. M. (2000). Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 44, 1255-1265.
6. Bard, M., Lees, N. D., Turi, T., Craft, D., Cofrin, L., Barbuch, R., Koegel, C. & Loper, J. C. (1993). Sterol synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans. Lipids 28, 963-967.
7. Barns, S. M., Lane, D. J., Sogin, M. L., Bibeau, C. & Weisburg, W. G. (1991). Evolutionary relationships among pathogenic Candida species and relatives. J Bacteriol 173, 2250-2255.
8. Chevallier, M. R., Jund, R. & Lacroute, F. (1975). Characterization of cytosine permeation in Saccharomyces cerevisiae. J Bacteriol 122, 629-641.
9. de Kruijff, B. & Demel, R. A. (1974). Polyene antibiotic-sterol interactions in membranes of acholeplasma-laidlawii cells and lecithin liposomes. 3. Molecular structure of polyene antibiotic-cholesterol complexes. Biochim Biophys Acta 339, 57-70.
10. de Kruijff, B., Gerritsen, W. J., Oerleman, A., Demel, R. A. & Van Deenen, L. L. M. (1974). Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 1. Specificity of membrane-permeability changes induced by polyene antibiotics. Biochim Biophys Acta 339, 30-43.
11. de Montigny, J., Kern, L., Hubert, J. C. & Lacroute, F. (1990). Cloning and sequencing of URA10, a second gene encoding orotate phosphoribosyl transferase in Saccharomyces cerevisiae. Curr Genet 17, 105-111.
12. Elfopouios, G. M. & Moellering, R. C., Jr (1991). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn, pp. 432-492. Edited by U. Lorian. Baltimore, MD: Williams & Wilkins.
13. Erbs, P., Exinger, F. & Jund, R. (1997). Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr Genet 31, 1-6.
14. 19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism. Antimicrob Agents Chemother 34, 1996-2006.
15. Ghannoum, M. A. & Rice, L. B. (1999). Antifungal agents mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12, 501-517.
16. Gietz, R. D. & Schiestl, R. H. (1995). Transforming yeast with DNA. Methods Mol Cell Biol 5, 255-269.
17. Gueldener, U., Heinisch, J., Koehler, G. J., Voss, D. & Hegemann, J. H. (2002). A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast. Nucleic Acids Res 30, e23.
18. Hartmann, K. U. & Heidelberger, C. (1961). Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase. J Biol Chem 236, 3006-3013.
19. Hendriks, L., Goris, A., Neefs, J., van de Peer, Y., Hiennebert, G. & de Wachter, R. (1989). The nucleotide sequence of the small ribosomal subunit RNA of the yeast Candida albicans and the evolutionary position of the fungi among the eukaryotes. Syst Appl Microbiol 12, 223-229.
20. Hitchcock, C. A. (1991). Cytochrome P-450-dependent 14a-sterol demethylase of Candida albicans and its interaction with azole antifungals. Biochem Soc Trans 19, 782-787.
21. Johnson, D. M., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R. & Rex, J. R. (2004). Combination antifungal therapy. Antimicrob Agents Chemother 48, 693-715.
22. Joseph-Horne, T. & Hollomon, D. W. (1997). Molecular mechanisms of azole resistance in fungi. FEMS Microbiol Lett 149, 141-149.
23. Jund, R. & Lacroute, F. (1970). Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J Bacteriol 102, 607-615.
24. Kaiser, C., Michaelis, S. & Mitchell, A. (1994). Methods in Yeast Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. Kalb, V. F., Woods, C. W., Turi, T. G., Dey, C. R., Sutter, T. R. & Loper, J. C. (1987). Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA 6, 529-537.
26. Kelly, S. L., Lamb, D. C., Corran, A. J., Baldwin, B. C. & Kelly, D. E. (1995). Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3-beta,6-alpha-diol. Biochem Biophys Res Commun 207, 910-915.
27. Kern, L., de Montigny, J., Jund, J. & Lacroute, F. (1990). The FUR1 gene of Saccharomyces cerevisiae: Cloning, structure and expression of wild-type and mutant alleles. Gene 88, 149-157.
28. Kurtz, J. E., Exinger, F., Erbs, P. & Jund, R. (1999). New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: Requirement of six genes for cytidine metabolism. Curr Genet 36, 130-136.
29. Lupetti, A., Danesi, R., Campa, M., Del Tacca, M. & Kelly, S. (2002). Molecular basis of resistance to azole antifungals. Trends Mol Med 8, 76-81.
30. Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A. & Ghannoum, M. A. (2005). Combination treatment of invasive fungal infections. Clin Microbiol Rev 18, 163-194.
31. NCCLS (1998). Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: Proposed standard M38-P. Wayne, PA: National Committee for Clinical Laboratory Standards.
32. Paluszynski, J. P., Klassen, R., Rohe, M. & Meinhardt, F. (2006). Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Yeast 23, 707-715.
33. Peters, G. J., Laurensse, E., Lankelma, J., Leyva, A. & Pinedo, H. M. (1984). Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil nucleotide sugars. Eur J Cancer Clin Oncol 20, 1425-1431.
34. Polak, A. & Scholer, H. (1975). Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21, 113-130.
35. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Harbor, NY: Cold Spring Harbor Laboratory.
36. Sanglard, D., Ischer, F., Parkinson, T., Falconer, D. & Bille, J. (2003). Candida albicans mutations in the ergosterol biosynthesis pathway and resistance to several other agents. Antimicrob Agents Chemother 47, 2404-2412.
37. Schwarz, P., Dromer, F., Lortholary, O. & Dannaoui, E. (2003). In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother 47, 3361-3364.
38. Schwarz, P., Dromer, F., Lortholary, O. & Dannaoui, E. (2006). Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother 50, 113-120.
39. Schwarz, P., Janbon, G., Dromer, F., Lortholary, O. & Dannaoui, E. (2007). Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 51, 383-385.
40. Smith, S. J., Crowley, J. H. & Parks, L. W. (1996). Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae. Mol Cell Biol 16, 5427-5432.
41. Southern, E. M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98, 503-517.
42. Te Dorsthorst, D. T. A., Verweij, P. E., Meletiadis, J., Bergervoet, M., Punt, N. C., Meis, J. F. G. M. & Mouton, J. W. (2002). In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach. Antimicrob Agents Chemother 46, 2982-2989.
43. Vanden Bossche, H. (1985). Biochemical targets for antifungal azole derivatives: Hypothesis on the mode of action. In Current Topics in Medical Mycology, vol. 1, pp. 313-351. Edited by M. R. McGinnis. New York: Springer-Verlag.
44. Vanden Bossche, H., Willemsens, G. & Marichal, P. (1987). Anti- Candida drugs: The biochemical analysis for their activity. Crit Rev Microbiol 15, 57-72.
45. Vanden Bossche, H., Marichal, P., Odds, F. C., Jeune, L. & Coene, M. C. (1992). Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 36, 2602-2610.
46. Vanden Bossche, H., Marichal, P. & Odds, F. C. (1994). Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2, 393-400.
47. Wach, A., Brachat, A., Pöhlmann, R. & Philippsen, P. (1994). New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10, 1793-1808.
48. Wadler, S., Horowitz, R., Zhang, H. Y. & Schwartz, E. L. (1998). Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells. Biochem Pharmacol 55, 1353-1360.
49. Watson, P. F., Rose, M. E. & Kelly, S. L. (1988). Isolation and analysis of ketoconazole mutants of Saccharomyces cerevisiae. J Med Vet Mycol 26, 153-162.
50. Watson, P. F., Rose, M. E., Ellis, S. W., England, H. & Kelly, S. L. (1989). Defective sterol C5-6 desaturation and azole resistance: A new hypothesis for the mode of action of azole anti-fungals. Biochem Biophys Res Commun 164, 1170-1175.
51. Whelan, W. L. (1987). The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit Rev Microbiol 15, 45-56.
52. Yanisch-Perron, C., Viera, J. & Messing, J. (1985). Improved M13 phage cloning vectors and host strains: Nucleotide sequence of the M13mp18 and pUC19 vectors. Gene 33, 103-119.